期刊
MOLECULAR PHARMACEUTICS
卷 15, 期 2, 页码 609-618出版社
AMER CHEMICAL SOC
DOI: 10.1021/acs.molpharmaceut.7b00961
关键词
vascular cell adhesion molecule-1; single chain variable fragment; Ga-68; positron-emission tomography; therapy monitoring
资金
- National Natural Science Foundation of China [81271623, 81630049]
- Clinical Research Physician Program of Tongji Medical College, Huazhong University of Science and Technology [5001530008]
Vascular cell adhesion molecule-1 (VCAM-1) is a transmembrane glycoprotein closely related to tumorigenicity as well as tumor metastasis. It is also a well-known candidate for detecting tumors. LY2409881, an IKK beta inhibitor, could induce apoptosis of VCAM-1 positive cells. Our purpose is to prepare a novel tracer to evaluate its feasibility of detecting VCAM-1 expression and monitoring LY2409881 tumor curative effect. The tracer was prepared by conjugating the single chain variable fragment (scFv) of VCAM-1 and NOTA-NHS-ester and then labeled with Ga-68. Ga-68-NOTA-VCAM-1(scFv) was successfully prepared with high radiochemical yield. VCAM-1 overexpression and underexpression melanoma cell lines, B16F10 and A375m, were used in this study. The results of microPET/CT imaging in small animals indicated that the uptake of Ga-68-NOTA-VCAM-1(scFv) in B16F10 tumor was much higher than that of A375m, which was also confirmed by the biodistribution and autoradiography results. LY2409881 inhibits the growth of B16F10 melanoma in vivo by inducing dose- and time-dependent growth inhibition and apoptosis of the cells. The LY2409881 treated group and DMSO control group were established and imaged by microPET/CT. In the LY2409881 group, uptake of the tracer in tumor was decreased at the first week, and then gradually recovered to the initial level. In DMSO control, the uptake of the tracer remained at the same level during the whole time. The results suggested that LY2409881 inhibits the expression of VCAM-1 and suppresses tumor growth. Ga-68-NOTA-VCAM-1(scFv), an easily synthesized probe, has a potential clinical application in the visual monitoring of IKK beta inhibitor intervention on VCAM-1 positive tumors.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据